tiprankstipranks
Advertisement
Advertisement

IONS Stock Latest News

McCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
Weekend UpdatesMcCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
2d ago
ECL
MKC
Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating
3d ago
IONS
Ionis Pharmaceuticals price target raised to $93 from $90 at BofA
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $93 from $90 at BofA
4d ago
IONS
Ionis Pharmaceuticals price target lowered to $115 from $125 at H.C. Wainwright
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $115 from $125 at H.C. Wainwright
4d ago
IONS
Ionis Pharmaceuticals price target raised to $69 from $66 at Goldman Sachs
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $69 from $66 at Goldman Sachs
4d ago
IONS
Ionis Expands Rare Disease Reach With Pediatric FCS Trial for Olezarsen
PremiumCompany AnnouncementsIonis Expands Rare Disease Reach With Pediatric FCS Trial for Olezarsen
5d ago
IONS
Ionis Pharmaceuticals announces chief scientific officer Bennett to retire
Premium
The Fly
Ionis Pharmaceuticals announces chief scientific officer Bennett to retire
5d ago
IONS
Ionis Pharmaceuticals reports Q2 EPS (69c), consensus (88c)
Premium
The Fly
Ionis Pharmaceuticals reports Q2 EPS (69c), consensus (88c)
5d ago
IONS
Is IONS a Buy, Before Earnings?
PremiumPre-Earnings
Is IONS a Buy, Before Earnings?
7d ago
IONS
Ionis Buy Rating Reaffirmed as TRYNGOLZA Lead and Competitive Edge Support Unchanged $125 Price Target
PremiumRatings
Ionis Buy Rating Reaffirmed as TRYNGOLZA Lead and Competitive Edge Support Unchanged $125 Price Target
11d ago
IONS
Ionis Maintains Buy Rating as Olezarsen’s sHTG Profile Outshines Rival; $86 Price Target Reaffirmed
PremiumRatings
Ionis Maintains Buy Rating as Olezarsen’s sHTG Profile Outshines Rival; $86 Price Target Reaffirmed
12d ago
IONS
Ionis Pharmaceuticals price target lowered to $89 from $106 at Guggenheim
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $89 from $106 at Guggenheim
13d ago
IONS
Wolfe cuts Ionis Pharma to Peer Perform after disappointing trial data
PremiumThe FlyWolfe cuts Ionis Pharma to Peer Perform after disappointing trial data
18d ago
AMGN
IONS
Ionis Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
Premium
The Fly
Ionis Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
18d ago
IONS
Ionis Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Ionis Pharmaceuticals call volume above normal and directionally bullish
18d ago
IONS
Ionis says Biogen presents Phase 2 CELIA data at AAIC
PremiumThe Fly
Ionis says Biogen presents Phase 2 CELIA data at AAIC
20d ago
BIIB
IONS
Arrowhead initiated with a Buy at Stifel
PremiumThe Fly
Arrowhead initiated with a Buy at Stifel
20d ago
ARWR
IONS
Midday Fly By: Apple sues OpenAI, MGM in talks with Diller’s People
PremiumThe Fly
Midday Fly By: Apple sues OpenAI, MGM in talks with Diller’s People
21d ago
T
BX
Alnylam price target raised to $485 from $470 at H.C. Wainwright
PremiumThe Fly
Alnylam price target raised to $485 from $470 at H.C. Wainwright
21d ago
AZN
ALNY
Ionis Pharmaceuticals price target lowered to $85 from $100 at RBC Capital
PremiumThe FlyIonis Pharmaceuticals price target lowered to $85 from $100 at RBC Capital
21d ago
IONS
Ionis Pharmaceuticals doses first participant in Phase 1-2 ASCEND study
Premium
The Fly
Ionis Pharmaceuticals doses first participant in Phase 1-2 ASCEND study
21d ago
IONS
H.C. Wainwright trims Ionis price target, says trial failure reaction ‘overdone’
Premium
The Fly
H.C. Wainwright trims Ionis price target, says trial failure reaction ‘overdone’
24d ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >